These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24167671)

  • 1. Improvements to the FIGO staging for ovarian cancer: reconsideration of lymphatic spread and intraoperative tumor rupture.
    Suh DH; Kim TH; Kim JW; Kim SY; Kim HS; Lee TS; Chung HH; Kim YB; Park NH; Song YS
    J Gynecol Oncol; 2013 Oct; 24(4):352-8. PubMed ID: 24167671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restaging and Survival Analysis of 4036 Ovarian Cancer Patients According to the 2013 FIGO Classification for Ovarian, Fallopian Tube, and Primary Peritoneal Cancer.
    Rosendahl M; Høgdall CK; Mosgaard BJ
    Int J Gynecol Cancer; 2016 May; 26(4):680-7. PubMed ID: 26937751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The new FIGO staging system for ovarian, fallopian tube, and primary peritoneal cancer.
    Zeppernick F; Meinhold-Heerlein I
    Arch Gynecol Obstet; 2014 Nov; 290(5):839-42. PubMed ID: 25082067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Federation of gynecology and obstetrics staging classification for cancer of the ovary, fallopian tube, and peritoneum: estimation of survival in patients with node-positive epithelial ovarian cancer.
    Pereira A; Pérez-Medina T; Magrina JF; Magtibay PM; Rodríguez-Tapia A; Peregrin I; Mendizabal E; Ortiz-Quintana L
    Int J Gynecol Cancer; 2015 Jan; 25(1):49-54. PubMed ID: 25405578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective study for investigating the relationship between old and new staging systems with prognosis in ovarian cancer using gynecologic cancer registry of Japan Society of Obstetrics and Gynecology (JSOG): disparity between serous carcinoma and clear cell carcinoma.
    Yamagami W; Nagase S; Takahashi F; Ino K; Hachisuga T; Mikami M; Enomoto T; Katabuchi H; Aoki D
    J Gynecol Oncol; 2020 Jul; 31(4):e45. PubMed ID: 32026659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer of the ovary, fallopian tube, and peritoneum.
    Berek JS; Kehoe ST; Kumar L; Friedlander M
    Int J Gynaecol Obstet; 2018 Oct; 143 Suppl 2():59-78. PubMed ID: 30306591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer of the ovary, fallopian tube, and peritoneum: 2021 update.
    Berek JS; Renz M; Kehoe S; Kumar L; Friedlander M
    Int J Gynaecol Obstet; 2021 Oct; 155 Suppl 1(Suppl 1):61-85. PubMed ID: 34669199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.
    Gasimli K; Braicu EI; Nassir M; Richter R; Babayeva A; Chekerov R; Darb-Esfahani S; Sehouli J; Muallem MZ
    Ann Surg Oncol; 2016 Apr; 23(4):1279-86. PubMed ID: 26832880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stage IIIC ovarian/peritoneal serous carcinoma: a heterogeneous group of patients with different prognoses.
    Bakkar R; Gershenson D; Fox P; Vu K; Zenali M; Silva E
    Int J Gynecol Pathol; 2014 May; 33(3):302-8. PubMed ID: 24681743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian, fallopian tube and peritoneal cancer staging: Rationale and explanation of new FIGO staging 2013.
    Prat J
    Best Pract Res Clin Obstet Gynaecol; 2015 Aug; 29(6):858-69. PubMed ID: 25890882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging.
    Powless CA; Aletti GD; Bakkum-Gamez JN; Cliby WA
    Gynecol Oncol; 2011 Sep; 122(3):536-40. PubMed ID: 21636114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival analysis of revised 2013 FIGO staging classification of epithelial ovarian cancer and comparison with previous FIGO staging classification.
    Paik ES; Lee YY; Lee EJ; Choi CH; Kim TJ; Lee JW; Bae DS; Kim BG
    Obstet Gynecol Sci; 2015 Mar; 58(2):124-34. PubMed ID: 25798426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum.
    Prat J;
    Cancer; 2015 Oct; 121(19):3452-4. PubMed ID: 26110780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the new FIGO 2013 classification on prognosis of stage I epithelial ovarian cancers.
    Montavon Sartorius C; Mirza U; Schötzau A; Mackay G; Fink D; Hacker NF; Heinzelmann-Schwarz V
    Cancer Manag Res; 2018; 10():4709-4718. PubMed ID: 30410404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
    Ma R; Zhang H; Zou L; Qu Y
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New FIGO classification of ovarian, fallopian tube and primary peritoneal cancer].
    Höhn AK; Einenkel J; Wittekind C; Horn LC
    Pathologe; 2014 Jul; 35(4):322-6. PubMed ID: 24899496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
    Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
    Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retroperitoneal nodal metastasis in primary and recurrent granulosa cell tumors of the ovary.
    Abu-Rustum NR; Restivo A; Ivy J; Soslow R; Sabbatini P; Sonoda Y; Barakat RR; Chi DS
    Gynecol Oncol; 2006 Oct; 103(1):31-4. PubMed ID: 16537089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity of the 2014 FIGO Stage IIIA1 Subclassification for Ovarian, Fallopian Tube, and Peritoneal Cancers.
    Matsuoka A; Tate S; Nishikimi K; Iwamoto M; Otsuka S; Shozu M
    In Vivo; 2022; 36(5):2453-2460. PubMed ID: 36099140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic performance of the 2023 FIGO staging schema for endometrial cancer.
    Matsuo K; Chen L; Klar M; Lee MW; Machida H; Mikami M; Muderspach LI; Carlson JW; Roman LD; Wright JD
    Gynecol Oncol; 2024 Aug; 187():37-45. PubMed ID: 38713997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.